941294-27-5 Usage
General Description
7-Chloro-4-methyl-1H-indole, also known as 4-Chloro-7-methylindole, is an organic compound with the molecular formula C9H8ClN. It is a chlorinated derivative of methylindole, a bicyclic aromatic compound commonly found in organic synthesis and in certain natural products. This chemical is primarily used as an intermediate in the production of pharmaceuticals, agrochemicals, and dyes. Its unique structure and properties make it valuable in various chemical reactions and as a building block for other complex molecules. Additionally, it is considered a potential environmental contaminant and may have adverse effects on human health and the environment if not properly handled and disposed of.
Check Digit Verification of cas no
The CAS Registry Mumber 941294-27-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,1,2,9 and 4 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 941294-27:
(8*9)+(7*4)+(6*1)+(5*2)+(4*9)+(3*4)+(2*2)+(1*7)=175
175 % 10 = 5
So 941294-27-5 is a valid CAS Registry Number.
941294-27-5Relevant articles and documents
17 BETA HSD TYPE 5 INHIBITOR
-
Page/Page column 22, (2008/12/08)
To provide a novel and excellent method for treating and/or preventing prostatic cancer, benign prostatic hyperplasia, acne, seborrhea, hirsutism, baldness, alopecia, precocious puberty, adrenal hypertrophy, polycystic ovary syndrome, breast cancer, lung cancer, endometriosis, leiomyoma and the like based on selective inhibitory activity against 17βHSD type 5. It was found that an N-sulfonylindole derivative, where the indole ring is substituted by a carboxy group, a carboxy-substituted lower alkyl group or a carboxy-substituted lower alkenyl group at its carbon atom, has potent selective inhibitory activity against 17βHSD type 5 and may become a therapeutic agent and/or preventive agent for benign prostatic hyperplasia, prostatic cancer and the like without accompanying adverse drug reactions due to a decrease in testosterone; and the present invention has thus been completed.
